Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (64,668) $ (37,728)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation 59,691 58,935
Amortization 114,281 95,473
Deferred income tax benefit (6,946) (35,444)
Amortization of debt issuance costs, and discount/premium, net 6,881 6,413
Non-cash compensation expense 17,919 32,192
Unrealized changes in fair value of contingent consideration (2,564) (8,908)
Loss (gain) on sale of operating assets (195) 635
Equity in earnings of nonconsolidated affiliates (5,682) (2,772)
Other, net 791 2,904
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable (103,344) (148,233)
Increase in prepaid expenses (305,090) (138,161)
Increase in other assets (62,284) (55,756)
Increase in accounts payable, accrued expenses and other liabilities 94,717 69,903
Increase in deferred revenue 566,621 293,212
Net cash provided by operating activities 310,128 132,665
CASH FLOWS FROM INVESTING ACTIVITIES    
Collections and advances of notes receivable 566 (626)
Distributions from nonconsolidated affiliates 703 7,481
Investments made in nonconsolidated affiliates (2,858) (5,926)
Purchases of property, plant and equipment (62,785) (44,651)
Proceeds from disposal of operating assets, net of cash divested 5,648 7,163
Cash paid for acquisitions, net of cash acquired (68,093) (19,904)
Purchases of intangible assets (11,469) (103)
Other, net (269) (525)
Net cash used in investing activities (138,557) (57,091)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 58,270 (756)
Payments on long-term debt (44,222) (15,081)
Contributions from noncontrolling interests 130 0
Distributions to and purchases/sales of noncontrolling interests, net (8,189) (59,999)
Proceeds from exercise of stock options 859 3,082
Proceeds from sale of common stock 0 76,492
Payments for deferred and contingent consideration (10,585) (13,807)
Net cash used in financing activities (3,737) (10,069)
Effect of exchange rate changes on cash and cash equivalents (7,048) 45,697
Net increase in cash and cash equivalents 160,786 111,202
Cash and cash equivalents at beginning of period 844,253 892,758
Cash and cash equivalents at end of period $ 1,005,039 $ 1,003,960